Back

Does evidence-based treatment recommendations implementation improve 1-year outcomes in patients with heart failure?

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Heart failure risk: from inflammation to prediction Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Maria Anguita Gamez

University Hospital Infanta Sofia, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Sex differences in cardiovascular inflammation defined by high-sensitivity C-reactive protein across heart failure phenotypes: insights from POSEIDON
Professor S. Stoerk (Wuerzburg, DE)
Abstract
Presentation thumbnail
From desalination to deficiency: shifting magnesium-related mortality in heart failure patients
Doctor K. Faierstein (Ramat Gan, IL)
Abstract
Presentation thumbnail
Prevalence of high inflammatory risk across heart failure subtypes in Europe: a sub-analysis of the global POSEIDON study
Professor J. Muller-Ehmsen (Bremen, DE)
Abstract
Presentation thumbnail
Risk of major adverse cardiovascular events after RSV-related hospitalization among US adults with heart failure
Doctor D. Bhatt (New York City, US)
Abstract
Presentation thumbnail
Sex differences in cardiorenometabolic syndrome across heart failure: prognostic impact in a low-middle income country
Doctor A. Jordan (Mexico City, MX)
Abstract

Access the full session

Session thumbnail
Heart failure risk: from inflammation to prediction

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Incidence of 1-year mortality, heart failure admissions and decompensation in patients with heart failure followed in HF units in Spain. Differences according to type of units.
30 August 2024
thumbnail
Webinar
How to implement new heart failure therapies in clinical practice
1 December 2022
thumbnail
Congress Presentation
What is the adherence to ARNI and iSGLT2 treatment in heart failure patients with reduced ejection fraction in a real world population?
29 June 2021
thumbnail
Congress Presentation
Changes in the characteristics and treatment of heart failure in Spain (2019-2024): are evidence-based recommendations and clinical practice guidelines being implemented?
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources